Citius Pharmaceuticals, Inc. (CTXR) stock
CTXRNasdaqPharmaceutical PreparationsFiscal year ends September 30
$0.50−0.01 (-2.64%)
Close on Nov 19, 2026Market cap $13.65MP/E –Yield –
Citius Pharmaceuticals free cash flow
Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.
Citius Pharmaceuticals's free cash flow for the twelve months ending Sep 30, 2021 was -$24.26M. For fiscal 2021 it was -$24.26M.
Annual free cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2021 | Sep 30, 2021 | -$24.26M | – |
| FY2020 | Sep 30, 2020 | -$16.93M | – |
| FY2017 | Sep 30, 2017 | -$7.97M | – |
Quarterly free cash flow
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q4 FY2021CQ3 2021 | Sep 30, 2021 | -$5.59M | – |
| Q4 FY2020CQ3 2020 | Sep 30, 2020 | -$3.36M | – |
See a number that looks wrong?